CD40 ligand and tdTomato-armed vaccinia virus for induction of antitumor immune response and tumor imaging
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CD40 ligand and tdTomato-armed vaccinia virus for induction of antitumor immune response and tumor imaging
Authors
Keywords
-
Journal
GENE THERAPY
Volume 21, Issue 2, Pages 195-204
Publisher
Springer Nature
Online
2013-12-05
DOI
10.1038/gt.2013.73
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immune Response Is an Important Aspect of the Antitumor Effect Produced by a CD40L-Encoding Oncolytic Adenovirus
- (2012) I. Diaconu et al. CANCER RESEARCH
- Oncolytic Immunotherapy of Advanced Solid Tumors with a CD40L-Expressing Replicating Adenovirus: Assessment of Safety and Immunologic Responses in Patients
- (2012) S. Pesonen et al. CANCER RESEARCH
- Inflammasomes in carcinogenesis and anticancer immune responses
- (2012) Laurence Zitvogel et al. NATURE IMMUNOLOGY
- The secret ally: immunostimulation by anticancer drugs
- (2012) Lorenzo Galluzzi et al. NATURE REVIEWS DRUG DISCOVERY
- Recent successes of cancer immunotherapy: a new dimension in personalized medicine?
- (2012) Christophe Caux et al. Targeted Oncology
- Prerequisites for the Antitumor Vaccine-Like Effect of Chemotherapy and Radiotherapy
- (2011) Dalil Hannani et al. CANCER JOURNAL
- Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans
- (2011) Caroline J. Breitbach et al. NATURE
- CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans
- (2011) G. L. Beatty et al. SCIENCE
- Tumor Cell Death and ATP Release Prime Dendritic Cells and Efficient Anticancer Immunity
- (2010) L. Aymeric et al. CANCER RESEARCH
- Adenovirus-mediated CD40L gene therapy induced both humoral and cellular immunity against rat model of hepatocellular carcinoma
- (2010) Tomonori Iida et al. CANCER SCIENCE
- Synergistic Interaction Between Oncolytic Viruses Augments Tumor Killing
- (2010) Fabrice Le Boeuf et al. MOLECULAR THERAPY
- Efficient Adenovector CD40 Ligand Immunotherapy of Canine Malignant Melanoma
- (2009) Henrik von Euler et al. JOURNAL OF IMMUNOTHERAPY
- The co-translocation of ERp57 and calreticulin determines the immunogenicity of cell death
- (2008) T Panaretakis et al. CELL DEATH AND DIFFERENTIATION
- CD40ligand‐expressing dendritic cells induce regression of hepatocellular carcinoma by activating innate and acquired immunity in vivo
- (2008) Maria A. Gonzalez‐Carmona et al. HEPATOLOGY
- Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial
- (2008) Byeong-Ho Park et al. LANCET ONCOLOGY
- Improving the photostability of bright monomeric orange and red fluorescent proteins
- (2008) Nathan C Shaner et al. NATURE METHODS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation